Literature DB >> 21936859

Bleeding in essential thrombocythaemia: a retrospective analysis on 565 patients.

Francesca Palandri, Nicola Polverelli, Lucia Catani, Daria Sollazzo, Emanuela Ottaviani, Sarah Parisi, Michele Baccarani, Nicola Vianelli.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21936859     DOI： 10.1111/j.1365-2141.2011.08858.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

Review 1.  The underappreciated risk of thrombosis and bleeding in patients with myelofibrosis: a review.

Authors:  Devendra Kc; Lorenzo Falchi; Srdan Verstovsek
Journal:  Ann Hematol       Date:  2017-08-14       Impact factor: 3.673

2.  The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib.

Authors:  Jennifer M O'Sullivan; Angela Hamblin; Christina Yap; Sonia Fox; Rebecca Boucher; Anesh Panchal; Samah Alimam; Helene Dreau; Kieran Howard; Pauline Ware; Nicholas C P Cross; Mary Frances McMullin; Claire N Harrison; Adam J Mead
Journal:  Blood       Date:  2019-12-05       Impact factor: 22.113

3.  Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).

Authors:  Joanna Rupa-Matysek; Krzysztof Lewandowski; Maria Lewandowska; Ewelina Wojtasińska; Marzena Liliana Wojtaszewska; Michał Walczak; Ksenia Bykowska; Mieczysław Komarnicki
Journal:  Int J Hematol       Date:  2014-11-29       Impact factor: 2.490

Review 4.  Low-risk polycythemia vera and essential thrombocythemia: management considerations and future directions.

Authors:  Hannah Goulart; John Mascarenhas; Douglas Tremblay
Journal:  Ann Hematol       Date:  2022-03-28       Impact factor: 3.673

5.  Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study.

Authors:  Yoshinori Hashimoto; Tomoki Ito; Akihiko Gotoh; Mika Nakamae; Fumihiko Kimura; Michiaki Koike; Keita Kirito; Hideho Wada; Kensuke Usuki; Takayuki Tanaka; Takehiko Mori; Satoshi Wakita; Toshiki I Saito; Akiko Kada; Akiko M Saito; Kazuya Shimoda; Yuka Sugimoto; Toshiro Kurokawa; Akihiro Tomita; Yoko Edahiro; Koichi Akashi; Itaru Matsumura; Katsuto Takenaka; Norio Komatsu
Journal:  Int J Hematol       Date:  2021-11-02       Impact factor: 2.490

Review 6.  The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer.

Authors:  Chanukya K Colonne; Emmanuel J Favaloro; Leonardo Pasalic
Journal:  Healthcare (Basel)       Date:  2022-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.